IN2014MU01194A - - Google Patents
Info
- Publication number
- IN2014MU01194A IN2014MU01194A IN1194MU2014A IN2014MU01194A IN 2014MU01194 A IN2014MU01194 A IN 2014MU01194A IN 1194MU2014 A IN1194MU2014 A IN 1194MU2014A IN 2014MU01194 A IN2014MU01194 A IN 2014MU01194A
- Authority
- IN
- India
- Prior art keywords
- acceptable derivative
- pharmaceutical
- sulbactam
- cefepime
- stereoisomer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020167027684A KR20160130824A (ko) | 2014-03-29 | 2015-01-14 | 세페파임 또는 술박탐을 포함하는 제약학적 조성물 |
| US15/300,113 US20170151221A1 (en) | 2014-03-29 | 2015-01-14 | Pharmaceutical compositions comprising cefepime or sulbactam |
| BR112016022439A BR112016022439A2 (pt) | 2014-03-29 | 2015-01-14 | Composições farmacêuticas que compreendem cefepima ou sulbactama |
| CN201580017231.6A CN106900171A (zh) | 2014-03-29 | 2015-01-14 | 包含头孢吡肟或舒巴坦的药物组合物 |
| IN1194MU2014 IN2014MU01194A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2014-03-29 | 2015-01-14 | |
| EP15706531.9A EP3125887A1 (en) | 2014-03-29 | 2015-01-14 | Pharmaceutical compositions comprising cefepime or sulbactam |
| JP2016558575A JP2017508769A (ja) | 2014-03-29 | 2015-01-14 | セフェピムまたはスルバクタムを含む医薬組成物 |
| MX2016012646A MX2016012646A (es) | 2014-03-29 | 2015-01-14 | Composiciones farmaceuticas que comprenden agentes antibacterianos. |
| PCT/IB2015/050268 WO2015150926A1 (en) | 2014-03-29 | 2015-01-14 | Pharmaceutical compositions comprising cefepime or sulbactam |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1194MU2014 IN2014MU01194A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2014-03-29 | 2015-01-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU01194A true IN2014MU01194A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2015-10-02 |
Family
ID=54239460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1194MU2014 IN2014MU01194A (c_deeref_Disk_and_Scratch_Disk_Pools_and_Their_Defaults.html) | 2014-03-29 | 2015-01-14 |
Country Status (9)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230365561A1 (en) * | 2020-09-01 | 2023-11-16 | Ningxia Academy Of Agricul Ture And Forestry Sciences | Beta-lactamase inhibitors and their preparation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5269415B2 (ja) * | 2004-12-02 | 2013-08-21 | ヴィーナス・レメディーズ・リミテッド | 注射に有用なβ−ラクタマーゼ阻害剤を使用したβ−ラクタマーゼ媒介性の抗生物質耐性を抑制する組成物 |
| PT2714034T (pt) * | 2011-05-28 | 2018-10-30 | Wockhardt Ltd | Composições que compreendem cefepime e tazobactam |
| CN103648496B (zh) * | 2011-07-26 | 2016-05-25 | 沃克哈特有限公司 | 包含β-内酰胺抗生素、舒巴坦和β-内酰胺酶抑制剂的药物组合物 |
| AU2011373911B2 (en) * | 2011-07-26 | 2016-09-22 | Wockhardt Limited | Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor |
| JP5666743B2 (ja) * | 2011-08-27 | 2015-02-12 | ウォックハート リミテッド | １，６−ジアザビシクロ［３，２，１］オクタン−７−オン誘導体および細菌感染の処置におけるそれらの使用 |
| US8796257B2 (en) * | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| WO2014033560A1 (en) * | 2012-08-25 | 2014-03-06 | Wockhardt Limited | 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections |
| WO2014141132A1 (en) * | 2013-03-14 | 2014-09-18 | Naeja Pharmaceutical Inc. | NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS |
-
2015
- 2015-01-14 KR KR1020167027684A patent/KR20160130824A/ko not_active Withdrawn
- 2015-01-14 JP JP2016558575A patent/JP2017508769A/ja active Pending
- 2015-01-14 MX MX2016012646A patent/MX2016012646A/es unknown
- 2015-01-14 WO PCT/IB2015/050268 patent/WO2015150926A1/en active Application Filing
- 2015-01-14 IN IN1194MU2014 patent/IN2014MU01194A/en unknown
- 2015-01-14 EP EP15706531.9A patent/EP3125887A1/en not_active Withdrawn
- 2015-01-14 CN CN201580017231.6A patent/CN106900171A/zh active Pending
- 2015-01-14 US US15/300,113 patent/US20170151221A1/en not_active Abandoned
- 2015-01-14 BR BR112016022439A patent/BR112016022439A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017508769A (ja) | 2017-03-30 |
| CN106900171A (zh) | 2017-06-27 |
| EP3125887A1 (en) | 2017-02-08 |
| KR20160130824A (ko) | 2016-11-14 |
| US20170151221A1 (en) | 2017-06-01 |
| BR112016022439A2 (pt) | 2017-08-15 |
| MX2016012646A (es) | 2016-10-28 |
| WO2015150926A1 (en) | 2015-10-08 |